BriaCell Therapeutics Corp. (8BT)
FSX
Closed
Oct 8, 2026
Day's Range
3.3852 wk Range
2.22Overview - 8BT - BriaCell Therapeutics Corp.
Key Statistics
Valuation
Enterprise Value
6.22M
P/E (Trailing)
‪-0.08‬
PEG Ratio
‪0.00083‬
Price / Book
‪1.19‬
EV / EBITDA
‪-0.21‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-90.84%‬
Return on Equity
‪-175.25%‬
Ownership
Shares Outstanding
7.25M
Float
7.85M
Held by Insiders
‪0.04%‬
Held by Institutions
‪6.39%‬
Price stats
Beta
‪1.53‬
50-Day Avg
‪3.12‬
200-Day Avg
‪3.36‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 8BT - BriaCell Therapeutics Corp.
Peers - 8BT - BriaCell Therapeutics Corp.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 8BTFSXBriaCell Therapeutics Corp.32.71MMarket Cap-215.71%52-week change-0.08P/E (Trailing)‪0.00%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - 8BT - BriaCell Therapeutics Corp.
About
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer. BriaCell Therapeutics Corp. is best known for its cell-based oncology programs, including Bria-IMT, a lead therapy being studied for metastatic breast cancer, along with Bria-OTS, a…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
